FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2597309601> ?p ?o ?g. }

• W2597309601 endingPage "401" @default.
• W2597309601 startingPage "401" @default.
• W2597309601 abstract "Abstract C5-blockade with eculizumab prevents complement-mediated intravascular hemolysis in PNH patients and its clinical consequences. However, a distinct population of PNH red blood cells bound with C3 fragments appears in almost all treated patients. This C3 binding results in extravascular hemolysis that in some patients reduces the clinical benefit from eculizumab. In each PNH patients on eculizumab there are always two distinct populations of PNH red blood cells, one with (C3+) and one without (C3-) C3 binding. This phenomenon is somehow paradoxical since the glycosylphosphatidylinositol (GPI)-linked complement regulators, CD55 and CD59, are uniformly deficient on the surface of PNH red cells. To investigate this phenomenon, we have modeled in vitro the C3 binding in the context of C5 blockade by incubating red blood cells from PNH patients with AB0-matched sera from patients on eculizumab. Complement alternative pathway has been activated by mild acidification (in presence of Mg/EGTA to prevent the activation of complement classical pathway) and C3 binding has been assessed by flow cytometry at serial time points. In these experimental conditions a fraction of PNH red blood cells, similar to what happens in vivo, become promptly C3+ and its size increases with the time: from 9.4±2.7% after 5 minutes to 21.2±9.5% after 24 hours. The membrane defects of PNH cells suggested that the deficiency of CD55, which regulates the formation and accelerates the dissociation of C3 convertases, should be responsible for C3 binding to PNH red blood cells in presence of eculizumab (Parker CJ. Hematology Am Soc Hematol Educ Program. 2011;2011:21-29). In order to verify experimentally this hypothesis we have inactivated CD55 or CD59 on normal red blood cells by using blocking monoclonal antibodies (moAb - listed in the figure legend), and we have tested them in vitro upon activation of complement alternative pathway by mild acidification in presence or absence of C5 blockade. We found that CD55 inactivation on normal red blood cells results neither in hemolysis (without C5 blockade) nor in any C3 binding (with C5 blockade). As expected without C5 blockade CD59-inactivated normal red blood cells undergo hemolysis but, surprisingly, we found that in presence of C5 blockade they become bound with C3 fragments (Figure 1), just as it occurs in vivo in PNH patients on eculizumab. The simultaneous inactivation of both CD55 and CD59 further increased the level of C3 binding. Thus, at variance with the starting hypothesis, the deficiency of CD59, not that of CD55, plays the major role in C3 binding to PNH red cells of patients on eculizumab. Therapeutic C5 blockade in PNH patients has unmasked a novel function of CD59: in addition to prevent MAC formation, it plays a central role also in the regulation of C3 activation on cell surface through molecular mechanisms not elucidated yet. It remains to be established the physiological role, if any, of this novel function of CD59 and whether it play a role in determining the pleomorphic clinical features of the congenital CD59 deficiency. Finally, these findings may lead to investigate innovative approaches to reduce C3 binding and extravascular hemolysis in PNH patients on eculizumab and, in a broader context, to modulate complement activity. Figure 1 Figure 1. Disclosures Risitano: Novartis: Research Funding; Alexion Pharmaceuticals: Other: lecture fees, Research Funding; Rapharma: Research Funding; Alnylam: Research Funding." @default.
• W2597309601 created "2017-03-23" @default.
• W2597309601 creator A5019461567 @default.
• W2597309601 creator A5033266739 @default.
• W2597309601 creator A5035943674 @default.
• W2597309601 creator A5049668306 @default.
• W2597309601 creator A5051992892 @default.
• W2597309601 creator A5066104942 @default.
• W2597309601 date "2016-12-02" @default.
• W2597309601 modified "2023-10-12" @default.
• W2597309601 title "CD59 Deficiency Is Critical for C3 Binding on Red Blood Cells of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) during Anti-C5 Treatment (eculizumab)" @default.
• W2597309601 doi "https://doi.org/10.1182/blood.v128.22.401.401" @default.
• W2597309601 hasPublicationYear "2016" @default.
• W2597309601 type Work @default.
• W2597309601 sameAs 2597309601 @default.
• W2597309601 citedByCount "6" @default.
• W2597309601 countsByYear W25973096012018 @default.
• W2597309601 countsByYear W25973096012020 @default.
• W2597309601 countsByYear W25973096012022 @default.
• W2597309601 crossrefType "journal-article" @default.
• W2597309601 hasAuthorship W2597309601A5019461567 @default.
• W2597309601 hasAuthorship W2597309601A5033266739 @default.
• W2597309601 hasAuthorship W2597309601A5035943674 @default.
• W2597309601 hasAuthorship W2597309601A5049668306 @default.
• W2597309601 hasAuthorship W2597309601A5051992892 @default.
• W2597309601 hasAuthorship W2597309601A5066104942 @default.
• W2597309601 hasConcept C111684460 @default.
• W2597309601 hasConcept C126322002 @default.
• W2597309601 hasConcept C151730666 @default.
• W2597309601 hasConcept C159654299 @default.
• W2597309601 hasConcept C171279029 @default.
• W2597309601 hasConcept C184404459 @default.
• W2597309601 hasConcept C185592680 @default.
• W2597309601 hasConcept C189446657 @default.
• W2597309601 hasConcept C203014093 @default.
• W2597309601 hasConcept C2776557347 @default.
• W2597309601 hasConcept C2777346216 @default.
• W2597309601 hasConcept C2777991916 @default.
• W2597309601 hasConcept C2778639011 @default.
• W2597309601 hasConcept C2779343474 @default.
• W2597309601 hasConcept C2779902561 @default.
• W2597309601 hasConcept C2908647359 @default.
• W2597309601 hasConcept C71318922 @default.
• W2597309601 hasConcept C71924100 @default.
• W2597309601 hasConcept C79196540 @default.
• W2597309601 hasConcept C86803240 @default.
• W2597309601 hasConcept C99454951 @default.
• W2597309601 hasConceptScore W2597309601C111684460 @default.
• W2597309601 hasConceptScore W2597309601C126322002 @default.
• W2597309601 hasConceptScore W2597309601C151730666 @default.
• W2597309601 hasConceptScore W2597309601C159654299 @default.
• W2597309601 hasConceptScore W2597309601C171279029 @default.
• W2597309601 hasConceptScore W2597309601C184404459 @default.
• W2597309601 hasConceptScore W2597309601C185592680 @default.
• W2597309601 hasConceptScore W2597309601C189446657 @default.
• W2597309601 hasConceptScore W2597309601C203014093 @default.
• W2597309601 hasConceptScore W2597309601C2776557347 @default.
• W2597309601 hasConceptScore W2597309601C2777346216 @default.
• W2597309601 hasConceptScore W2597309601C2777991916 @default.
• W2597309601 hasConceptScore W2597309601C2778639011 @default.
• W2597309601 hasConceptScore W2597309601C2779343474 @default.
• W2597309601 hasConceptScore W2597309601C2779902561 @default.
• W2597309601 hasConceptScore W2597309601C2908647359 @default.
• W2597309601 hasConceptScore W2597309601C71318922 @default.
• W2597309601 hasConceptScore W2597309601C71924100 @default.
• W2597309601 hasConceptScore W2597309601C79196540 @default.
• W2597309601 hasConceptScore W2597309601C86803240 @default.
• W2597309601 hasConceptScore W2597309601C99454951 @default.
• W2597309601 hasIssue "22" @default.
• W2597309601 hasLocation W25973096011 @default.
• W2597309601 hasOpenAccess W2597309601 @default.
• W2597309601 hasPrimaryLocation W25973096011 @default.
• W2597309601 hasRelatedWork W2081653014 @default.
• W2597309601 hasRelatedWork W2149245783 @default.
• W2597309601 hasRelatedWork W2150466621 @default.
• W2597309601 hasRelatedWork W2170202743 @default.
• W2597309601 hasRelatedWork W2480622641 @default.
• W2597309601 hasRelatedWork W2978041444 @default.
• W2597309601 hasRelatedWork W2993389739 @default.
• W2597309601 hasRelatedWork W3098291647 @default.
• W2597309601 hasRelatedWork W4200015828 @default.
• W2597309601 hasRelatedWork W4253833116 @default.
• W2597309601 hasVolume "128" @default.
• W2597309601 isParatext "false" @default.
• W2597309601 isRetracted "false" @default.
• W2597309601 magId "2597309601" @default.
• W2597309601 workType "article" @default.